Morphine Sulfate
NDC Package 42858-810-17

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Morphine Sulfate is a medication used to treat severe pain. Marketed by Rhodes Pharmaceuticals L.p., this product is identified by NDC 42858-810 and is authorized under FDA application ANDA206308.

Identification & Billing

NDC Package Code
42858-810-17
Package Description
500 mL in 1 BOTTLE, PLASTIC
Product Code
11-Digit Billing Format
42858081017

Clinical Specifications

Proprietary Name
Morphine Sulfate
Dosage Form
-
Usage Information
This medication is used to treat severe pain. Morphine belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain.

Regulatory & Marketing

Labeler Name
Rhodes Pharmaceuticals L.p.
FDA Application #
ANDA206308
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
06-22-2017
End Marketing Date
04-17-2024
Listing Expiration
04-17-2024
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 42858-810-17 identifies a specific commercial package of 500 ml in 1 bottle, plastic of Morphine Sulfate, labeled by Rhodes Pharmaceuticals L.p.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Rhodes Pharmaceuticals L.p. on June 22, 2017. The current certification is valid through April 17, 2024.

What are the primary indications for this medication?

This medication is used to treat severe pain. Morphine belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain.

How is this Rhodes Pharmaceuticals L.p. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 42858081017. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
42858-810-17
11-Digit CMS (5-4-2)
42858-0810-17

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.